戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 from factor XII-deficient plasma by means of immunoadsorption.
2 rn (group 2) of anti-alphaGal antibody after immunoadsorption.
3 remit after treatment with plasmapheresis or immunoadsorption.
4 s were retrieved together from the digest by immunoadsorption.
5 pheresis (one suggested benefit) and one for immunoadsorption (also suggesting benefit).
6      13 subjects received five treatments of immunoadsorption and 10 subjects received no TA as contr
7                                              Immunoadsorption and competitive ELISA analysis suggest
8 mpatible patients underwent antigen-specific immunoadsorption and could be transplanted across the bl
9                     Functional studies using immunoadsorption and HCV cell culture models demonstrate
10       Using sucrose gradient centrifugation, immunoadsorption and immunofluorescence staining, we hav
11 levated toxin concentrations increased toxin immunoadsorption and the specific immunoadsorption of Ru
12        The up-regulation of nAChRs, shown by immunoadsorption and Western blotting, involved alpha4,
13 By means of sucrose gradient centrifugation, immunoadsorption, and confocal microscopy, we have shown
14 e targeting, density gradient sedimentation, immunoadsorption, and fluorescence microscopy analyses s
15 ti-A antibody titers were reduced acutely by immunoadsorption, and remained low during long-term foll
16 ibody titers were detected, antigen-specific immunoadsorption, anti-CD20 monoclonal antibody, and rec
17                                 Rituximab or immunoadsorption appeared to be promising preconditionin
18 ors, and anti-alphaGal antibody depletion by immunoadsorption before transplantation of high doses (2
19 emove IgG (plasma donation, plasma exchange, immunoadsorption); (c) diseases resulting in loss of IgG
20 nd consideration of plasmapheresis or use of immunoadsorption column in severe cases.
21 s study was to assess efficacy and safety of immunoadsorption column reuse in ABO-incompatible kidney
22 ncompatible kidney transplantation including immunoadsorption column reuse.
23 ncompatible kidney transplantation including immunoadsorption column reuse.
24 DNA (anti-dsDNA) were affinity isolated from immunoadsorption columns of F(ab')2 and dsDNA linked to
25                                              Immunoadsorption columns were reused after restoration.
26 methotrexate, cyclosporine A, bromocriptine, immunoadsorption columns, and hydroxychloroquine withdra
27                            Systems utilizing immunoadsorption columns, dextran sulfate cellulose colu
28 f approximately 0.03, and its elimination by immunoadsorption did not affect GR folding and GR.hsp90
29  describe here the recovery of p50(cdc37) in immunoadsorptions directed against the hsp90 cohorts FKB
30 antithymocyte globulin (ATG), extracorporeal immunoadsorption (EI), mycophenolate mofetil (MMF), anti
31                           The extracorporeal immunoadsorption (EIA) of anti-alphaGal antibodies using
32                   A course of extracorporeal immunoadsorption (EIA) of anti-Gal Ab using an immunoaff
33                                           Co-immunoadsorption experiments indicate that in TMAO each
34 screte complexes with p97 as demonstrated by immunoadsorption from HeLa cell extracts fractionated by
35           Removal of these autoantibodies by immunoadsorption has been shown to improve heart failure
36 0 (877 [49.85%]), and 500 mg (569 [32.34%]); immunoadsorption (IA) (145 [8.24%]), IVIG (663 [37.69%])
37 nts we recently proposed nonantigen-specific immunoadsorption (IA) and rituximab.
38 tization protocol including antigen-specific immunoadsorption (IA) on complement activation.
39  after desensitization with antigen-specific immunoadsorption (IA) results in good outcomes.
40 adaveric renal transplants immediately after immunoadsorption (IA) treatment to remove anti-HLA.
41 -S; n = 810), plasma exchange (PE; n = 192), immunoadsorption (IA; n = 38), other (n = 80), and unkno
42 plasma exchange [TPE] or ABO-A-trisaccharide immunoadsorption [IA]) and 1-year posttransplant.
43 the p60 in lysate, and elimination of p60 by immunoadsorption inactivates this fraction, with bioacti
44                                     However, immunoadsorption is costly, time consuming, and carries
45                            An alternative to immunoadsorption is neutralization of autoantibodies thr
46                                     In vitro immunoadsorption of alphaGal Ab from the serum did not c
47 uded thymectomy, splenectomy, extracorporeal immunoadsorption of anti-alpha Gal antibodies, and T-cel
48 ectomy or thymic irradiation, extracorporeal immunoadsorption of anti-alphaGal antibodies and T-cell
49                                 In addition, immunoadsorption of anti-alphaGal antibody (Ab) was perf
50 ressive regimen that included extracorporeal immunoadsorption of anti-alphaGal antibody and inhibitio
51 =2) underwent a nonmyeloablative regimen and immunoadsorption of anti-Gal(alpha)1,3Gal (Gal) antibody
52 etransplantation antithymocyte globulin, and immunoadsorption of anti-Gal(alpha)1-3Gal (Gal) antibody
53 n, porcine hematopoietic growth factors, and immunoadsorption of anti-Galalpha1,3Gal (Gal) antibody b
54                     DCM was attenuated after immunoadsorption of beta1AR IgG before transfer and by s
55 y, including antibody inhibition therapy and immunoadsorption of circulating autoantibodies.
56 eins possess PPIase homology domains, and co-immunoadsorption of cytoplasmic dynein with each is bloc
57 BP52 from reticulocyte lysate also yields co-immunoadsorption of cytoplasmic dynein, and we show that
58 n of cytoplasmic dynein, and we show that co-immunoadsorption of dynein is competed by a fragment of
59  hypotonic buffer without salt or detergent, immunoadsorption of either STAT1 or STAT2 from the resul
60                                              Immunoadsorption of FKBP52 from reticulocyte lysate also
61                                              Immunoadsorption of Glut4-containing vesicles with coval
62                                              Immunoadsorption of high-mobility group box 1 protein (H
63                                              Immunoadsorption of hsp90 from cytosol of HEK cells expr
64 ased toxin immunoadsorption and the specific immunoadsorption of Ru-labeled antibodies to alpha toxin
65                We have previously shown that immunoadsorption of the FKBP52 immunophilin component of
66 n of VLA-5, an effect suppressed by specific immunoadsorption of the fragments.
67 clonal antibody, and multiple extracorporeal immunoadsorptions of anti-alphaGal antibodies.
68 elective apheresis techniques (cytapheresis, immunoadsorption) offer theoretical advantages but their
69 l graft survival for recipients who received immunoadsorption or apheresis was 94.1% (95% confidence
70 lin-lowering/modulating therapies, including immunoadsorption, plasma exchange, and high-dose intrave
71                               A total of 394 immunoadsorption procedures were performed with reused f
72 tioning regimen without an organ transplant, immunoadsorption reduced Ab by approximately 90%, but re
73 d a titer rise of 2 dilutions treated with 1 immunoadsorption session.
74                                              Immunoadsorption studies showed that AAbeta1AR and AAM2R
75 rect immunofluorescence, immunoblotting, and immunoadsorption studies.
76 selected for CD34+ cells by an avidin-biotin immunoadsorption technique.
77 bodies from the circulation through specific immunoadsorption therapy has the potential to ameliorate
78                       For IgG-mediated AIBD, immunoadsorption therapy is a convenient treatment modal
79 nation from the circulation through specific immunoadsorption therapy thus has the potential to ameli
80                     Oligosaccharide-specific immunoadsorption therapy thus provides a new therapeutic
81          Using subcellular fractionation and immunoadsorption to enrich for specific membrane fractio
82                Using specific antibodies and immunoadsorption to protein A/Sepharose columns, we foun
83               Antigen-specific perioperative immunoadsorption was performed.
84           The median number of pretransplant immunoadsorptions was 5.
85 ng either intravenous immunoglobulins and/or immunoadsorption will be critically discussed.
86 by either heat inactivation of complement or immunoadsorption with anti-C3 antibodies failed to depre
87 otein, and can be depleted of infectivity by immunoadsorption with anti-FasL antibody.
88                 One such complex obtained by immunoadsorption with anti-Ras antibody of cytosol prepa
89 rom cell-free tumor culture supernatants via immunoadsorption with OV569 and used to generate murine
90 lization activity that was reduced following immunoadsorption with the G protein.